The Incidence of Tonsillectomy in Covid-19 Patients and its Effect on The Course of The Disease

Tonsillectomy COVID-19 Immune System Symptomatic Disease ICU Referral SARS-CoV-2 Turkey

Authors

  • Yavuz Sultan Selim Yıldırım Department of Otorhinolaryngology, Elazig Fethi Sekin City Hospital, Clinic of Otorhinolaryngology, Elazig, Turkey., Türkiye
  • Semih Ak Department of Otorhinolaryngology, Semih Ak Prive Clinic, Sanliurfa, Turkey., Türkiye
Vol. 3 No. 06 (2024)
Original Article
November 17, 2024

Downloads

Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19) was identified for the first time in the Hubei province of China and spread around the world.1 The first COVID-19 case was diagnosed on the 11th of March 2020 in Turkey and spread across the country. Methods: Patients diagnosed with COVID-19 and admitted to Health Sciences University, Elazığ Fethi Sekin Training and Research Hospital and Health Sciences University Sanliurfa Mehmet Akif Inan Training and Research Hospital via polymerase chain reaction (PCR) test between May 2021 and September 2021 constituted the target population of this study. Results: In patients with a history of tonsillectomy, the rate of symptomatic patients was significantly higher than those without a history of tonsillectomy. There were no patients with a history of tonsillectomy among the patients referred to ICU and there was no statistically significant association between these two parameters. Conclusion: Since our study lacks long-term follow-up data and the long-term consequences of symptomatic COVID-19 are uncertain, we suggest that COVID-19 patients with history of tonsillectomy should be warned about the higher risk of developing symptomatic disease.

Similar Articles

You may also start an advanced similarity search for this article.